Dr Xiaonan Zhong is a clinician-scientist and emerging leader in neuroimmunology, specialising in multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). She is a Senior Research Fellow at the Perron Institute and The University of Western Australia. 

Dr Zhong completed her medical training and Doctor of Medicine at Sun Yat-sen University in China, where she progressed to Associate Chief Physician, before completing a PhD in Medicine at UWA. This combination of clinical neurology and laboratory research enables her to connect disease mechanisms with the complex treatment decisions facing patients and clinicians. 

Her research investigates the genetic, immunological and biological factors that influence neuroinflammatory disease activity, progression and treatment response. Her work spans genomics, biomarkers, immune regulation, clinical imaging and precision medicine, including international clinical trials and global collaborations such as the Atlas of Multiple Sclerosis. 

Dr Zhong has authored 50 peer-reviewed publications, including 24 as first or senior author, attracting more than 1,220 citations. Five of her papers rank among the world’s top 10 per cent most cited publications, and she has secured three competitive grants as lead investigator. She has also contributed to national expert consensus guidelines for MS and related neuroimmune disorders. 

Through her research, Dr Zhong aims to translate complex biological information into safer, more personalised care—helping clinicians make better-informed decisions and improving outcomes for people living with MS and related conditions. 

View Publications    Email Xiaonan